ezogabine has been researched along with 2,2,5,7,8-pentamethyl-1-hydroxychroman in 1 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (2,2,5,7,8-pentamethyl-1-hydroxychroman) | Trials (2,2,5,7,8-pentamethyl-1-hydroxychroman) | Recent Studies (post-2010) (2,2,5,7,8-pentamethyl-1-hydroxychroman) |
---|---|---|---|---|---|
383 | 26 | 241 | 141 | 1 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calloe, K; Elmedyb, P; Grunnet, M; Hansen, RS; Olesen, SP; Schmitt, N | 1 |
1 other study(ies) available for ezogabine and 2,2,5,7,8-pentamethyl-1-hydroxychroman
Article | Year |
---|---|
Modulation of ERG channels by XE991.
Topics: Acetylcholine; Animals; Anthracenes; Carbamates; Cell Line; Chromans; Dose-Response Relationship, Drug; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gene Expression; Indoles; Oocytes; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyridines; Xenopus laevis | 2007 |